West Virginia University Logo

July 2, 2014


SAMHSA Prescription Drug Abuse Weekly Update
Issue 78  |  July 2, 2014
The Prevention of Prescription Drug Abuse in the Workplace (PAW) TA Center addresses prescription drug abuse—a growing public health problem with increasing burdens on workers, workplaces, and our economy. To subscribe colleagues, family members, or friends to this listserv sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), please click here or send their e-mail addresses to paw@dsgonline.com.
Table of Content Featured Article Journal Articles and Reports Professional Education & Editorial News Other State and Local News Webinar Video Request for Proposal Take-Back Events and Drop Boxes Save the Date Upcoming Conferences and Workshops


D.V. Canfield, J.E. Whinnery, R.J. Lewis, and K.M. Dubowski. 2014. "A New Equation for Calculating the Maximum Wait Time for Pilots Who Use an Impairing Medication." Aviation, Space, and Environmental Medicine 85(6):668–71.

Researchers developed an equation based on the therapeutic range and maximum expected half-life of an impairing medication to calculate a safe return-to-duty time for pilots. The equation assumes the treating physician will not dose the patient beyond the upper therapeutic range of the medication and the person taking the medication has the three-hour maximum half-life reported in the literature. Blood and plasma were collected from volunteers at two to three hours after dosing and again after another five hours. One subject taking a 25-mg dose had a 0.033 ug per ml blood concentration after waiting eight hours, well above the 0.025 ug per ml level reported as impairing concentration. The authors recommend shifting to a mean wait time of four half-lives for 18 impairing medications.

Read more:

Journal Articles and Reports

T.J. Cicero, M.S. Ellisa, H.L. Surratt, and S.P. Kurtz. 2014. "Factors Contributing to the Rise of Buprenorphine Misuse: 2008–13." Drug and Alcohol Dependence, doi:10.1016/j.drugalcdep.2014.06.005.

Misuse of buprenorphine increased substantially in the last five years according to a nationwide survey of 10,568 patients entering substance abuse treatment programs for opioid dependence. The survey was supplemented by open-ended interviews with 208 patients. Motives for misuse included to get high, to manage withdrawal sickness, to substitute for more preferred drugs, to treat pain, to manage psychiatric issues, and as a self-directed effort to wean off opioids.

Read more:

S. Coupland, R. Fraser, J. Palacios–Boix, D.A. Charney, J–C. Negrete, and K.J. Gill. 2014. "Illicit and Prescription Opiate Dependence: The Impact of Axis II Psychiatric Comorbidity on Detoxification Outcome." Journal of Addiction Research and Therapy S10:008, doi: 10.4172/2155–6105.S10–008

This study compared outcomes of inpatient treatment for opiate dependence versus sedative–hypnotic (including alcohol) dependence among 203 consecutive Canadian detoxification patients. All protocols managed withdrawal through tapering and daily medical/psychiatric monitoring. The 88 opiate-dependent patients were significantly less likely to complete detoxification and more likely to drop out against medical advice or to be discharged for noncompliance, compared with the 115 sedative–hypnotic dependent patients. Controlling for substance used, younger age, and presence of a Cluster B personality disorder decreased the odds of treatment completion. Those with opiate dependence were more likely to be polysubstance abusers, and to report that they suffered some form of chronic pain syndrome, compared with the nonopiate group. Among opiate-dependent patients, 31.6 percent suffered from both a chronic pain condition and a personality disorder, compared with 4.0 percent of nonopiate patients. Illicit opiate users were significantly younger than prescription opiate users at first use and at the time of detoxification.

Read more:

B.L. Greenfield, M.D. Owens, and D. Ley. 2014. "Opioid Use in Albuquerque, New Mexico: A Needs Assessment of Recent Changes and Treatment Availability." Addiction Science & Clinical Practice 9:10, doi:10.1186/1940–0640–9–10.

Semistructured interviews in 2011 with 24 substance use treatment agencies and eight key stakeholders in Albuquerque, N.M., revealed a noticeable increase in youths' seeking treatment for opioid use and a general increase in nonmedical prescription opioid use. Factors that respondents said prevent opioid users from quickly accessing effective treatment are primarily buprenorphine providers and a lack of youth services, with stigma, limited interagency communication and referral, barriers to prescribing buprenorphine, and a lack of funding also contributing.

Read more:

T.M. Hammett, S. Phan, J. Gaggin, P. Case, N. Zaller, A. Lutnick, A.H. Kral, E.V. Fedorova, R. Heimer, W. Small, R. Pollini, L. Beletsky, C. Latkin, and D.C. Des Jarlais. 2014. "Pharmacies as Providers of Expanded Health Services for People Who Inject Drugs: A Review of Laws, Policies, and Barriers in Six Countries." BMC Health Services Research 14:261, doi:10.1186/1472–6963–14–261

Qualitative and quantitative interviews with stakeholders and a review of legal and policy documents in the Canada, China, Mexico, Russia, United States, and Vietnam assessed the feasibility of expanded pharmacy services for people who inject drugs illicitly. Provision of information and referrals by pharmacies is permissible in all study sites, and sale and safe disposal of needles/syringes by pharmacies is legal in almost all sites, although needle/syringe sales face challenges related to attitudes and practices of pharmacists, police, and other actors. Pharmacy provision of HIV testing, hepatitis vaccination, opioid substitution treatment, naloxone for drug overdose, and abscess treatment face legal and policy barriers.

Read more:

N.B. King, V. Fraser, C. Boikos, R. Richardson, and S. Harper. 2014. "Determinants of Increased Opioid-Related Mortality in the United States and Canada, 1990–2013: A Systematic Review." American Journal of Public Health 12:e1–e11, doi:10.2105/AJPH.2014.301966

A literature review identified 17 causes of increased opioid-related mortality and morbidity in the United States and Canada between 1990 and 2013. The causes fell into three categories: prescriber behavior, user behavior and characteristics, and environmental and systemic determinants. Most studies were ecological or observational and lacked control groups or adjustment for confounding factors.

Read more:

B.K. Larson, M.E. Eisenberg, and M.D. Resnick. 2014. "Engagement in Risk Behaviors Among Adolescents Who Misuse Prescription Drugs: Evidence for Subgroups of Misusers." Journal of Substance Use 19(4):334–39, doi:10.3109/14659891.2013.810308.

Using Minnesota Student Survey data (n=64,997), this study added to the growing evidence that multiproblem youths are typically the high school students who misuse prescription drugs. Risk behaviors analyzed were multiple sexual partners, binge drinking, vandalism, self-harm, and suicide ideation. Differences were larger for externalizing risk behaviors (number of sexual partners, binge drinking, vandalism), especially among females.

Read more:

T.S. Schepis and J.K. Hakes. 2014. "The Association Between Nonmedical Use of Prescription Medication Status and Change in Health-Related Quality of Life: Results From a Nationally Representative Survey." Drug and Alcohol Dependence, doi: 10.1016/j.drugalcdep.2014.06.009

Health-related quality of life correlates inversely with nonmedical use of prescription medication status. Short Form–12 Health Survey (SF–12) data from 34,653 persons who completed both waves 1 and 2 of the National Epidemiological Survey on Alcoholism and Related Conditions showed that, across medication classes, persons who began nonmedical prescription medication use between waves had greater declines or smaller increases in quality of life than other people. Persons with a history of nonmedical use but no use between waves had the most favorable change in SF–12 scores, especially on the mental health scale.

Read more:

F. Schifano. 2014. "Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?" CNS Drugs 28(6):491–96, doi: 10.1007/s40263–014–0164–4.

This article reviewed the current evidence base of misuse potential for gabapentinoids in an attempt to answer the question of whether there is cause for concern about these drugs. Overall, pregabalin is characterized by higher potency, quicker absorption rates, and greater bioavailability levels than gabapentin. Although at therapeutic dosages gabapentinoids present with low addictive liability levels, misusers consider them as substitutes for illicit drugs. Gabapentinoid experimenters typically have a history of recreational polydrug misuse and take 3 to 20 times clinically advisable doses.

Read more:

M. Silvestri. 2014. "Normative Influences on the Nonmedical Use of Prescription Stimulants Among College Students." Auburn University Theses and Dissertations, June 18.

An online survey of 959 college students found that students overestimated the past-year prevalence of nonmedical use of prescription drugs. Perceived close friend and parental approval of nonmedical use was positively correlated with self-approval and personal nonmedical use in the past year.

Read more:

M.V. Smith, D. Costello, and K.A. Yonkers. 2014. "Clinical Correlates of Prescription Opioid Analgesic Use in Pregnancy." Maternal and Child Health Journal, doi:10.1007/s10995–014–1536–6

This study adds to the evidence that prescription opioid misuse correlates with other problem behaviors. Among 2,748 English- or Spanish-speaking pregnant women interviewed in New Haven, Conn., between March 2005 and May 2009, 6 percent reported using opioids at any point in their pregnancy. Opioid users were more likely to meet diagnostic criteria for major depressive disorder (16 percent versus 8 percent for nonusers), generalized anxiety disorder (18 percent versus 9 percent for nonusers), posttraumatic stress disorder (11 percent versus 4 percent for nonusers) and panic disorder (6 percent versus 4 percent for nonusers). They also were more likely to report smoking cigarettes in the second or third trimester of pregnancy and using illicit drugs.

Read more:

E.M. Sowa, J.C. Fellers, R.S. Raisinghani, M.R. Santa Cruz, P.C. Hidalgo, M.S. Lee, L.A. Martinez, A.E. Keller, and A.H. Clayton. 2014. "Prevalence of Substance Misuse in New Patients in an Outpatient Psychiatry Clinic Using a Prescription Monitoring Program." Primary Care Companion to CNS Disorders 16(1), doi: 10.4088/PCC.13m01566.

Researchers investigated the value of a prescription monitoring program (PMP) in identifying prescription drug misuse among 314 adult patients presenting to a resident physician outpatient psychiatry clinic at an academic medical center between October 2011 and June 2012. Virginia PMP reports suggested 41.7 percent of patients were misusers, defined as having any of the following in the PMP report: 1) filled prescriptions for two or more controlled substances, 2) obtained prescriptions from two or more providers, 3) obtained early refills, 4) used three or more pharmacies, or 5) the PMP report conflicted with the patient's report. More than 69 percent of patients whom residents believed were misusing prescription drugs met one of these criteria. The PMP report changed management only 2.2 percent of the time. Patients with prior benzodiazepine use, prior opioid use, a personality disorder, or chronic pain had higher prescription misuse probabilities than other patients.

Read more:

F.A. Wilson, J.P. Stimpson, and J.A. Pagan. 2014. "Fatal Crashes From Drivers Testing Positive for Drugs in the United States, 1993–2010." Public Health Reports 129: 342–50.

Fatality Analysis Reporting System data indicated that prescription drugs accounted for the highest fraction of drugs used by U.S. drivers in fatal crashes who tested positive for drugs positive in 2010. However, not all were tested.

Read more:

L. Xie, A.V. Joshi, D. Schaaf, J. Mardekian, J. Harnett, N.D. Shah, and O. Baser. 2014. "Differences in Healthcare Utilization and Associated Costs Between Patients Prescribed Versus Nonprescribed Opioids During an Inpatient or Emergency Department Visit." Pain Practice 14(5):446–56, doi: 10.1111/papr.12098. Epub 2013 Jun 30.

Of 27,599 patients in the MarketScan Commercial Claims and Encounters or Medicare Supplemental databases who were seen in a hospital's inpatient or emergency department between January 2007 to September 2009, 18,819 were prescribed opioids. Patients prescribed opioids were younger and more likely to be female, to reside in the southern United States, to have Preferred Provider Organization health plans, and to have low comorbidity index scores. They had fewer non-pain-related comorbidities but more pain-related comorbidities. In the year after their first opioid prescription, propensity-matched patients who were prescribed opioids had higher healthcare resource utilization and costs in total ($49,766 versus $19,875 in the matched sample) and in all subcategories (inpatient, outpatient emergency department, physician, pharmacy, other outpatient). Diagnosed opioid abuse within one year was low in patients treated for common diagnoses within three months before initial prescription (0.48 percent). Mean time from first prescription to abuse diagnosis was 201 days.

Read more:

Professional Education & Editorial

G.K. Alexander, S.B. Canclini, and D.L. Krauser. 2014. "Academic-Practice Collaboration in Nursing Education: Service-Learning for Injury Prevention." Nurse Educator 39(4):175–178, doi:10.1097/NNE.0000000000000044.

This article described a student-led process of community assessment, followed by systematic planning, implementation, and evaluation of evidence-based interventions to advance prescription drug overdose/poisoning prevention efforts in the community.

Read more:


Americans Weigh Addiction Risk When Taking Painkillers
Scott Hensley, National Public Radio
June 22, 2014

Most Americans have taken prescription opioids at some point in their lives. This article and audio (3 minutes 19 seconds) discuss a nationwide poll conducted in May by National Public Radio and Truven Health Analytics. The 3,010 respondents included people contacted by phone or over the Internet. The most common reason for using opioids was to relieve some kind of temporary pain: a sprained ankle, surgery, dental procedure. About 20 percent had taken the drugs for chronic pain. Seventy-eight percent said they believe there is a link between drug addiction and narcotic pain relievers. A quarter of those surveyed said they had refused or questioned a prescription for an opioid.

Read more:

More Stressed College Students Ordering Medications Online
Aimee Simone, Pharmacy Times
June 26, 2014

In the May 2014 annual Zogby Analytics survey, of 311 responding current and recently graduated college students, 32 percent said they or their friends took prescription drugs as study aids during final exams. Among users, 33 percent obtained the drugs without a physician's prescription. Men were more likely than women to use medications to help them study (38 percent versus 26 percent). Thirty-one percent of students said they or a friend had shared a legally prescribed medication with someone else, an 8 percent increase from last year. Students residing in the southern United States were most likely to share prescriptions. Approximately 28 percent of respondents said they or a friend had ordered drugs online without a prescription, up 13 percent from 2013.

Read more:

How to Sell the Prescription Painkiller Politicians Fear
John Tozzi, Bloomberg
June 24, 2014

Zogenix reported that about 9,000 prescriptions were filled from March when Zohyrdo rolled out through June 13. Despite opposition to the drug by numerous governors and state attorneys general, Zogenix is planning targeted marketing to the 20,000 high-decile (extended release/long acting) opioid prescribers who account for 60 percent of the opioid prescription market. Insurance companies are debating how they will cover the drug. Two forms of Zohydro intended to be more resistant to abuse by snorting, chewing, or injecting are planned for 2016.

Read more:

Fake Drug Enforcement Administration Agents Scamming People Out of Thousands
John Elizondo, KXXV
June 24, 2014

This article and video (2 minutes 5 seconds) discuss individuals posing as Drug Enforcement Administration agents. Law enforcement officials thus far have arrested 17 online prescription scammers who have scammed Americans out of more than $800,000. The scam begins when the victim buys foreign-produced prescription drugs online. A fake agent calls and claims the victim broke the law and must pay a fine or go to jail. The scammer lets the victim buy a temporary debit card and transfer the money to the fake agent over the phone. One person in Killeen, Texas, lost $18,000 protecting his wife from jail.

Read more:

Heroin Use Rising Sharply Since 2007, U.S. Mayors Told
June 23, 2014

Michael Botticelli, acting director of National Drug Control Policy for the White House, reported at a U.S. Conference of Mayors meeting that heroin use increased more than 80 percent nationwide from 2007 to 2012, driven by ample supply and a crackdown on prescription narcotics. He said that physicians in the United States prescribe enough pain relievers to medicate everyone in the country 24 hours a day for a month. He recommended that communities and law enforcers work with the public health sector and insurance companies to treat addicts.

Read more:

New South Wales Coroner Calls for Stricter Controls on Tranquilizer Drug Prescriptions to Prevent 'Doctor Shopping'
Alison Branley, ABC
June 27, 2014

The New South Wales, Australia, coroner called for authorities to make it more difficult to obtain tranquilizer drugs to help eliminate 'doctor shopping.' Deputy State Coroner Carmel Forbes handed down her findings about the deaths of three persons who overdosed on prescription medications. Coroner Forbes called for all drugs classed as benzodiazepines such as Serepax, Valium, and Mogadon to be moved from the less strict schedule 4 drug category to the harder-to-obtain schedule 8 category. Forbes also called for real-time prescription drug monitoring program services to allow general practitioners to see whether patients have been prescribed medications by other doctors that day or in recent months. The New South Wales government said it has been considering such a service but has not found a way to fund it. Forbes said more education on addiction was needed for general practitioners.

Read more:

Other State and Local News

Docs: Database Lag Aids Drug Abusers
Erin Smith and Matt Stout, Boston (Mass.) Herald
June 25, 2014

Dr. Richard S. Pieters, president of the Massachusetts Medical Society, said that some pharmacies report only who is receiving prescription opiates and other pain relievers to the prescription monitoring program about twice a month. The Department of Public Health expects technology upgrades to be completed by fall, allowing pharmacies to report to the database within one business day.

Read more:

Bitter Pill: Oxycodone Tops Massachusetts's List Among Missing Painkillers
Matt Stout and Erin Smith, Boston Herald
June 24, 2014

The Boston Herald obtained reports from Massachusetts pharmacies, distributors, and hospitals that showed tens of thousands of prescription pain relievers went missing or were stolen from Bay state stockroom shelves and delivery trucks last year. The state Board of Registration in Pharmacy received 349 reports of missing prescription drugs with a retail value of $319,000 for the 15-month period ending in May. Opiates were missing in 238 cases, including in nearly all of the 41 pharmacy armed robberies. Employee thefts accounted for 33 incidents. In 92 cases the reason for the drug disappearance was unknown.

Read more:

Bitter Pill: Prescription Rate for Oxycodone Soars
Matt Stout and Erin Smith, Boston Herald
June 23, 2014

This article and video (2 minutes 36 seconds) report that 30-mg tablets of oxycodone, dubbed "Roxy" or "Perc 30s" on the street, have overtaken Oxycontin as the drug of choice among abusers. Prescriptions for them spiked over the last three years in Massachusetts. A Boston Herald analysis of statewide data from May 2011 through April 2014 provided by Symphony Health Solutions, which tracks and analyzes drug trends, showed prescriptions for oxycodone increased 27 percent even though Oxycontin prescriptions increased by just 2 percent. Total prescriptions for pain medication more than doubled, from 17,829 in the first year to 46,525 in the third. Across more than 25 pediatric specialties, oxycodone prescriptions increased 34 percent, to reach more than 15,600 by the end of the three-year span.

Read more:

Cuomo Signs Legislation to Battle Heroin, Prescription Drug Scourge (With Video)
Tom Wrobleski, Staten Island Advance
June 23, 2014

New York Gov. Andrew Cuomo signed legislation to combat heroin and prescription drug abuse. One bill would require health insurance coverage for substance use disorder treatment services and create a workgroup to study and make recommendations for its implementation. The legislation increases the penalties for the criminal sale of a controlled substance by a pharmacist or practitioner by making the crime a class C felony. It also creates a new crime in the penal code of "fraud and deceit related to controlled substances" to crack down on doctor shopping. [Video duration: 7 minutes 42 seconds)

Read more:

Many Female Inmates of Cattaraugus County (N.Y.) Jail Addicted to Heroin, Prescription Drugs
Tom Donahue, Olean Times Herald
June 22, 2014

The Cattaraugus County sheriff told the New York state Senate's Joint Task Force on Heroin and Opioid Addiction that, of nearly a hundred male inmates in the county jail, 40 percent were addicted to heroin or prescription opiates. In the women's wing, of 23 inmates, 80 percent were addicted. The sheriff pushed for alternatives to jail time for nonviolent addicts.

Read more:

Monterey (Calif.) Hospital Unveils Database That Helps in Battle Against Prescription Drug Abuse
Tom Leyde, Monterey Herald News
June 25, 2014

Community Hospital of the Monterey Peninsula brought together all four county hospitals and other health and law enforcement agencies to concentrate on prescription drug abuse. It created the Monterey County Prescribe Safe Initiative. A list of prescription guidelines developed for health agencies included distributing a limited amount of pain medications for pain, declining to refill lost or stolen prescriptions, and using the prescription monitoring program.

Read more:

Lawmakers, Officials Push for Expanded Use of Heroin Antidote
Jameson Cook, Macomb Daily
June 23, 2014

A Michigan lawmaker said he expects passage this fall of legislation that allows third-party prescriptions of naloxone and requires first-responders to carry and know how to administer naloxone. The law will allow family members and friends of an addict to obtain a naloxone prescription. The law would exempt persons administering naloxone from criminal prosecution or civil responsibility in case of a mishap "as long as it is done in good faith." A House version of the bill passed this spring but time ran out on the Senate version before lawmakers recessed for the summer.

Read more:

Drug-Dependent Baby Influences Tennessee Prescription Drug Legislation
Olivia Caridi, WCYB
June 23, 2014

This article and video (2 minutes 6 seconds) discuss the increase in neonatal abstinence syndrome (NAS) among Tennessee infants. In 2003 there were 50 cases of NAS; in 2013 there were 921. At the beginning of June 2014, there were 420 cases in just one week. Tennessee Rep. Tony Shipley plans to introduce a bill addressing the problem in January.

Read more:

Nine Bills in Works to Attack Opiate Addiction
Michael D. Pitman, WHIO
June 24, 2014

This article discusses nine bills that Ohio legislators will consider in the fall to help reduce heroin and opiate addiction. House Bill 314 that prevents opioids from being prescribed to minors without their parents' consent. House Bill 359 that requires giving a consumer fact sheet to patients receiving an opioid prescription.

Read more:

Six Potent Painkillers
Boston Herald
June 23, 2014

Experts warn that abusing opioid prescriptions can put individuals at risk of opioid addiction, possibly leading to deadly street drugs.

Read more:

Heroin: From Prescription to Addiction (Part 1)
Mary Blake, WBZ NewsRadio 1030
June 2013

This article, part 1 of a series, discusses how prescription drug abuse and heroin use led to addiction among Massachusetts residents.

Read more:
Heroin: From Prescription to Addiction (Part 2)
Heroin: From Prescription to Addiction (Part 3)
Heroin: From Prescription to Addiction (Part 4)
Heroin: From Prescription to Addiction (Part 5)
Heroin: From Prescription to Addiction (Part 6)
Heroin: From Prescription to Addiction (Part 7)
Heroin: From Prescription to Addiction (Part 8)
Heroin: From Prescription to Addiction (Part 9)
Heroin: From Prescription to Addiction (Part 10)
Heroin: From Prescription to Addiction (Part 11)
Heroin: From Prescription to Addiction (Part 12)


Prescription Drugs and Medical Marijuana in the Workplace
July 16, 2014
10:00 a.m. (PDT)

This Webinar takes paying participants through the practical issues and legal principles that may regulate what you can and cannot do with an employee taking prescription medications and/or medical marijuana.

Read more:


Clinical Case Discussion on the Assessment and Management of Opioid Use Disorders in the General Hospital Setting
American Psychiatric Association
June 18, 2014

This presentation features a clinical case discussion on the assessment and management of opioid disorders in the general hospital setting. It provides guidance on how to assess and manage medical inpatients who may be requesting prescription opioids for nonmedical reasons. The session includes slides. [Duration: 1 hour 2 minutes 6 seconds]

Read more:

Request for Proposal

Chronic Pain Management Research Grant
Milbank Foundation
Postmarked by November 1, 2014

Take-Back Events and Drop Boxes

Operation Medicine Drop Keeps 61 Million Prescription Drug Doses From North Carolina Waters
North Carolina Headlines
June 26, 2014

You'll Soon Be Able to Drop Off Unwanted Meds 24/7 at Staten Island's NYPD Precincts
John M. Annese, Staten Island (N.Y.) Advance
June 25, 2014

CPSO Installs Permanent Drug Drop-Off Box for Public to Dispose of Unwanted Medication
KPLC (Louisiana)
June 20, 2014

Mission Police Acquire Permanent Bin for Prescription Drug 'Take Back' Every Day
Dan Blom, Prairie Village Post (Kansas)
June 25, 2014

Save the Date

Sixth Annual American Medicine Chest Challenge National Day of Awareness and Safe Disposal of Prescription and Over-the-Counter Medicine
American Medicine Chest Challenge
November 8, 2014

Upcoming Conferences and Workshops

Prescription Drug Abuse: Crisis in Oklahoma Workshop
Oklahoma Bureau of Narcotics & Dangerous Drugs Director Darrell Weaver
Friday, July 11, 2014
9:00 a.m. to 10:30 a.m.
East Central University
University Center
1100 East 14th Street
Ada, Oklahoma

This workshop will focus on prescription drug abuse, common drugs of abuse, the prescription monitoring program, and laws regarding prescription drugs.

Read more:

Pharmacy Diversion Awareness Conference
U.S. Department of Justice, Drug Enforcement Administration
July 12–13, 2014—Sheraton Philadelphia (Pa.) Downtown Hotel
August 2–3, 2014—Denver (Colo.) Marriott Tech Center

Clinical Challenges in Opioid Prescribing: Balancing Safety and Efficacy
Colorado Prescription Drug Abuse Prevention Program of Peer Assistance Services, Inc. SAMHSA
July 11, 2014
Denver, Colorado

CADCA's Midyear Training Institute 2014
July 20–24, 2014
Orlando, Florida

Prevention of Youth Substance Abuse in Rural Communities Conference: Bringing Hope to Communities in Despair
Coalition for Healthy Youth
August 6–8, 2014
Lancaster, South Carolina

Preventing Prescription Drug Abuse—Nonmembers
New Jersey Pharmacists Association
August 7, 2014
Secaucus, New Jersey

Twenty-Seventh Annual NPN Prevention Research Conference
National Prevention Network
September 15–18, 2014
Hartford, Connecticut

2014 Harold Rogers PDMP National Meeting
Brandeis University, Prescription Drug Monitoring Program Training and Technical Assistance Center
September 22–24, 2014
Washington, D.C.

142nd Annual Meeting and Exposition
American Public Health Association
November 15–19, 2014
New Orleans, Louisiana
The Weekly Update is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoint or opinion and are not assessed for validity, reliability or quality. The Weekly Update should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full text of journal articles listed in the Weekly Update.